NCI Initiatives in Cancer Diagnosis: Program Announcements (PA) and Requests for Applications (RFA)
The Cancer Diagnosis Program (CDP), often in cooperation with other programs of the NCI, offers a range of initiatives that encourage and support research in cancer diagnostics and related development of technology and specimen resources. These initiatives (Program Announcements & Requests for Applications) enable investigators to apply for several types of awards in addition to the standard (R01) research project grant. The review of applications in response to these initiatives may be conducted by special review groups. To learn about the specific features of each initiative, refer to the complete announcement in the NIH Guide for Grants and Contracts.
Active Program Announcements and Requests for Applications for
Exploratory Studies (R21 and R03 grants)
Technology Development
Clinical Correlative Studies
Phased Innovation Awards and Phased Application Awards (R21/R33 and R33 grants)
Human Tissue Specimen Resources
Small Business (SBIR and STTR grants)
Full List of Cancer Diagnosis Initiatives
The NCI's Division of Extramural Activities provides information on newly approved concepts for upcoming PAs and RFAs. Check this site for the earliest possible information on future initiatives:
Recently Cleared Concepts for Requests for Applications (RFAs) and Program Announcements (PAs)
